[ Inglés] Can Myeloma Patients Stop Treatment After Transplant?

Published on

Topics include: Treatments and Understanding

What’s next for multiple myeloma patients after a transplant? Can treatment be stopped altogether if patients have a good response? Myeloma expert Dr. Amrita Krishnan, from City of Hope, discusses the recommendations for post-transplant care and maintenance therapy based on clinical trial data gathered in Europe and the United States. Watch now to find out more.

This is a Patient Empowerment Network program produced by Patient Power. We thank AbbVie, Inc., Celgene Corporation, and Takeda Oncology for their support.

View more programs featuring and

Produced in association with

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Jack Aiello:

In the autologous setting we have differences right now.  We do have…

The French had a trial that actually started out with the same idea, indefinite lenalidomide.  They ended up abrogating it because of their concerns for toxicity.  The patients in that study had about 18 months of lenalidomide.  

And then lastly there's a big trial that's going on right now that the IFM Dana-Farber trial that in this French part patient after transplant might get lenalidomide only for a year.  The U.S. part patients get lenalidomide indefinitely, so it tells you that, you know, we can't really—don't know and we can't agree.  

The last point I would say is a trial, which you're very familiar with, Jack—you've been hugely instrumental in getting it off the ground, is trying to answer that very question, which is transplant get randomized to lenalidomide or lenalidomide and daratumumab (Darzalex), and then after two years if they're MRD negative, so really looking very, very deeply at their myeloma, patients will have a second randomization, so a group of patients both stop therapy, so that will answer the question can you stop therapy if you've had a very, very good response.  

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

Can Daily Exercise Impact Transplant Candidacy for Myeloma Patients?

A 25-year myeloma survivor, Jim Bond, shares his experience with the influence exercise has on transplant candidacy. Watch now to hear his tips.

Published:

Does the Transplant Treatment Approach Still Have Value for Myeloma Patients?

With the introduction of novel therapies, does the transplant treatment approach still have value for myeloma patients? Have transplants been replaced? Watch now to learn from myeloma experts what the latest data shows.

Published:

Are Transplants Still Needed in Myeloma?

With all of the advances in cancer care offered in what many call “the era of precision medicine,” are transplants still recommended for multiple myeloma treatment? Watch now as Dr. James Berenson gives an expert perspective on the current role of transplant in myeloma care.

Published:

Advertisement
Únete a Nuestra Comunidad Regístrate para Eventos Lee Nuestro Último Post
Advertisement

Page last updated on August 31, 2018